Ruxia Shi

No ORCID on file · 11 papers in corpus · active 2008-2023

Study types

  • article 9
  • other 1
  • preprint 1

Condition tags

  • endometriosis 6
  • adenomyosis 6
  • dysmenorrhea 3
  • infertility 1
  • endometrioma 1
  • die_deep_infiltrating 1
article 2023
·doi:10.31083/j.ceog5010224

Objective: The purpose of this review is to summarize drug selection for peri-menopausal symptoms caused by gonadotropin releasing-hormone agonist (GnRH-a) in the treatment of endometriosis. Mechanism: GnRH-a treatment often leads to low es…

article 2023
·doi:10.11648/j.jgo.20231102.15

Background: Diffuse uterine leiomyomatosis is a benign disease with a low incidence rate, mainly manifested as menorrhagia and infertility. Due to its clinical manifestations similar to multiple uterine myomas or adenomyosis, it is often mi…

article 2023
Scientific reports ·doi:10.1038/s41598-023-38034-8

Transumbilical single-port laparoscopy is widely used in gynecological surgery. However, it is rarely used in the treatment of deep infiltrating endometriosis due to its own shortcomings and the complex condition of deep infiltrating endome…

article 2023
·doi:10.31083/j.ceog5009183

Background: To evaluate the clinical efficacy and safety of the modified laparoscopic inverted triangle model for extended lesion resection in treating dysmenorrhea focal adenomyosis in women who have completed childbirth. Methods: A total …

other 2022
Frontiers in surgery ·doi:10.3389/fsurg.2022.914725

BACKGROUND AND OBJECTIVE: Adenomyosis focus resection has always been the main surgical method for patients with uterine preservation, but its curative effect and surgical method are still controversial. We improved this method on the basis…

preprint 2022
·doi:10.21203/rs.3.rs-1435202/v1

Abstract Objectives To evaluate the outcomes of women with uterine adenomyoma treated with combined modified laparoscopic adenomyomectomy and gonadotropin-releasing hormone (GnRH) agonists. Methods Between 2012 and 2016, 141 women with aden…

article 2022
·doi:10.11648/j.jgo.20221002.22

Background: Adenomyosis is caused by endometrial glands and stroma invading the myometrium. It is more common in parturients after the age of 30. At present, there are many drugs for the treatment of adenomyosis, and drug treatment is also …

article 2019
·doi:10.33552/wjgwh.2019.01.000521

Endometriosis (EMS) is a common estrogen-dependent gynecological disorder, which affects quality of life and fertility of productive-aged women [1]. Current treatment of EMS is mainly based on surgery and post-operative maintenance treatmen…

article 2018
Reproduction (Cambridge, England) ·doi:10.1530/rep-18-0112

It has been reported that the impaired cytotoxicity of natural killer (NK) cells and abnormal cytokines that are changed by the interaction between ectopic endometrial cells and immune cells is indispensable for the initiation and developme…

article 2016
Reproduction (Cambridge, England) ·doi:10.1530/rep-16-0089

Endometriosis (EMS) is associated with an abnormal immune response to endometrial cells, which can facilitate the implantation and proliferation of ectopic endometrial tissues. It has been reported that human endometrial stromal cells (ESCs…

article 2008